JILL DIMARTINIS: Open Payments
NPI 1225057565 · WELLS, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 17 payments from 9 companies in 2025. Trend: 2023 $37 · 2024 $0 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $194 |
| Amgen Inc. | 3 | $64 |
| ABBVIE INC. | 2 | $62 |
| Lilly USA, LLC | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| PFIZER INC. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
Products named: Ozempic, EVENITY, VRAYLAR, MOUNJARO, BREZTRI, Wegovy, AREXVY, PAXLOVID.
Industry payments across ME — which companies pay providers there.
